Cargando…

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells

BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Jia, Xu, Duo-Rong, Zheng, Fei-Meng, Long, Zi-Jie, Huang, Sheng-Shan, Wu, Xing, Zhou, Wei-Hua, Huang, Ren-Wei, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118333/
https://www.ncbi.nlm.nih.gov/pubmed/21595920
http://dx.doi.org/10.1186/1479-5876-9-71
Descripción
Sumario:BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that has shown cytotoxic activity in multiple cancers; however, its anti-cancer activity has not been well studied in DNR-insensitive CD34(+ )AML cells. The aim of this study was to therefore to explore curcumin-induced cytotoxicity in DNR-insensitive CD34(+ )AML cell lines (KG1a, Kasumi-1), DNR-sensitive U937 AML cells, and primary CD34(+ )AML bone-marrow-derived cells. METHODS: Primary human CD34(+ )cells were isolated from peripheral blood mononuclear cells or bone marrow mononuclear cells using a CD34 MicroBead kit. The growth inhibitory effects of curcumin were evaluated by MTT and colony-formation assays. Cell cycle distribution was examined by propidium iodide (PI) assay. Apoptosis was analyzed by Wright-Giemsa, Hoechst 33342 and Annexin-V/PI staining assays. The change in mitochondrial membrane potential (MMP) was examined by JC-1 staining and flow cytometry. Expression of apoptosis-related proteins was determined by reverse transcription-polymerase chain reaction and Western blotting. Short interfering RNA (siRNA) against Bcl-2 was used in CD34(+ )KG1a and Kasumi-1 cells incubated with/without DNR. RESULTS: Curcumin inhibited proliferation and induced apoptosis and G1/S arrest in both DNR-insensitive KG1a, Kasumi-1 and DNR-sensitive U937 cells. Curcumin-induced apoptosis was associated with reduced expression of both Bcl-2 mRNA and protein, subsequent loss of MMP, and activation of caspase-3 followed by PARP degradation. Curcumin synergistically enhanced the cytotoxic effect of DNR in DNR-insensitive KG1a and Kasumi-1 cells, consistent with decreased Bcl-2 expression. Accordingly, siRNA against Bcl-2 increased the susceptibility of KG1a and Kasumi-1 cells to DNR-induced apoptosis. More importantly, curcumin suppressed Bcl-2 expression, selectively inhibited proliferation and synergistically enhanced the cytotoxicity of DNR in primary CD34(+ )AML cells, while showing limited lethality in normal CD34(+ )hematopoietic progenitors. CONCLUSION: Curcumin down-regulates Bcl-2 and induces apoptosis in DNR-insensitive CD34(+ )AML cell lines and primary CD34(+ )AML cells.